Rutgers Health is leading the Pediatric Multiple Sclerosis and Demyelinating Diseases Program, the only program in the state of New [...]
Years ago, when many multiple sclerosis researchers believed that a type of immune cell known as a T-cell was the cause of the disease, Dr. [...]
Rockland, MA – EMD Serono, the biopharmaceutical company of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that [...]
June 28, 2019 (This news originally appeared in PharmaPhorum Website [...]
East Hanover, NJ. June 25, 2019. A recent study by Kessler Foundation researchers provided new findings about the nature of social [...]
The Billings Clinic hosted its first Multiple Sclerosis Health and Well-Being Symposium. It was a day-long educational seminar for people [...]
A study by the University of British Columbia made a scientific advance that researchers hope will lead to the development of preventative [...]
UCLA researchers are developing the first multiple sclerosis treatment that could target the cause of the disease, instead of simply [...]
Genentech to Present New OCREVUS (ocrelizumab) Data Analyses Showing Significant Reduction of Disability Progression in Relapsing and [...]
CHERRY HILL, N.J., May 2, 2019 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to recognize ten years of [...]